The status and future of carotid stenting: Who are the players and what is at stake?

Kenneth Cavanaugh, Lori Paserchia, Steve Phurrough, Dorothy Abel

Research output: Contribution to journalReview article

Abstract

The ongoing controversy regarding interventional treatment of carotid stenosis using intravascular stents involves not only identification of the appropriate clinical indications for this procedure, but also the adequacy of the regulatory processes involved with both the FDA approval of this technology and CMS reimbursement for the indicated population. The evolution of carotid stenting in the United States has been influenced by several interested parties, including the medical community, patient population and regulatory agencies, each with their own expectations and challenges. In this article, we describe the FDA approval and CMS coverage processes for carotid stenting with embolic protection, evaluate the effects of off-label use and medical practice on acceptance of this technology, and identify future challenges and approaches for both government and medicine.

Original languageEnglish (US)
Pages (from-to)255-259
Number of pages5
JournalVascular Disease Management
Volume3
Issue number3
StatePublished - May 1 2006

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cavanaugh, K., Paserchia, L., Phurrough, S., & Abel, D. (2006). The status and future of carotid stenting: Who are the players and what is at stake? Vascular Disease Management, 3(3), 255-259.